The report reveals that the Centers for Medicare & Medicaid Services’ (CMS) Long-Stay Antipsychotic Medication quality measure, while originally intended to prevent inappropriate use of antipsychotic drugs in nursing homes, has led to unintended consequences that restrict access to safe and effective treatments for more than 3 million residents with Alzheimer’s and related conditions.
New Film Distinguishes Various Risks and Treatments for Respiratory Viruses
Respiratory viruses like the common cold, influenza (flu), and COVID-19, are especially common during the fall and winter months. While these illnesses often start with similar symptoms, like a cough, fever, sore throat, or runny nose, they aren’t all the same. And understanding the differences can help you protect yourself and those around you, especially during this holiday season.
A new animated film, Respiratory Viruses: Often More Than a Sniffle, walks through everything you need to know this respiratory season: how to tell these viruses apart, when to test and treat, who’s most at risk for complications, and how vaccines can help prevent serious illness.
A new survey conducted by Wakefield Research on behalf of the Alliance and sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck Pharmaceuticals highlights the overall misconceptions about agitation in Alzheimer’s dementia, as well as the emotional strain and practical challenges facing caregivers of people living with symptoms of agitation in Alzheimer’s dementia.
Learn more about the survey findings, methodology, and the lived experiences of family caregivers supporting their loved ones with Alzheimer's dementia.
This interactive webinar will bring together experts, caregivers, and healthcare professionals to share real-world stories, practical tools, and evidence-based strategies for improving care and communication around Neuropsychiatric Symptoms of Alzheimer’s. This event is made possible with support from Lundbeck and Otsuka.
